Axa’s Green Plains GPRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,500
Closed -$264K 1150
2022
Q1
$264K Buy
+8,500
New +$267K ﹤0.01% 1120
2016
Q3
Sell
-5,616
Closed -$111K 1251
2016
Q2
$111K Hold
5,616
﹤0.01% 1235
2016
Q1
$90K Sell
5,616
-1,755
-24% -$28.2K ﹤0.01% 1220
2015
Q4
$169K Sell
7,371
-14,525
-66% -$308K ﹤0.01% 1195
2015
Q3
$426K Sell
21,896
-35,584
-62% -$785K ﹤0.01% 1077
2015
Q2
$1.58M Sell
57,480
-26,170
-31% -$805K 0.01% 843
2015
Q1
$2.39M Sell
83,650
-40,350
-33% -$1.01M 0.01% 764
2014
Q4
$3.07M Buy
124,000
+4,800
+4% +$144K 0.01% 685
2014
Q3
$4.46M Buy
119,200
+82,600
+226% +$3.3M 0.02% 566
2014
Q2
$1.2M Buy
36,600
+29,200
+395% +$859K 0.01% 886
2014
Q1
$222K Hold
7,400
﹤0.01% 1209
2013
Q4
$143K Buy
+7,400
New +$122K ﹤0.01% 1243

Other funds holding GPRE

Axa's GPRE Position: Q2 2022 in Review

Axa sold out of Green Plains (GPRE) in Q2 2022, closing a stake of 8,500 shares — an estimated $264K sold.

Axa first reported a position in GPRE in Q4 2013 and held it in 12 quarters. The position peaked at $4.46M in Q3 2014. 216 funds tracked by Wall St. Rank hold GPRE as of Q2 2022.

  • Axa reported no remaining Green Plains position as of Q2 2022 after selling out during the quarter.
  • Axa sold 8,500 Green Plains shares in Q2 2022, an estimated $264K.
  • Axa first reported a position in Green Plains in Q4 2013 and held it in 12 quarters.
  • Axa's Green Plains position peaked at $4.46M in Q3 2014.
  • 216 funds tracked by Wall St. Rank held Green Plains as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.